![]() Daiichi Sankyo Daiichi Sankyo (第一三共株式会社) is a company specializing in the research, development, and manufacture of innovative pharmaceutical products. | ![]() Bristol Myers Squibb Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. | ![]() Boehringer Ingelheim Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing. | ![]() AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | ||
Founding Date | Founding Date 2005 | Founding Date 1863 | Founding Date 1887 | Founding Date 1958 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Braine L'alleud, BE Sao Paulo, BR Toronto, CA Shanghai, CN see more | Locations Princeton, US HQ Mulgrave, AU Pinewood, AU Wien, AT Braine L'alleud, BE Bruxelles, BE São Paulo, BR see more | Locations Ingelheim am Rhein, DE HQ Ouled Fayet, DZ Munro, AR Macquarie Park, AU Wien, AT Minsk, BY Bruxelles, BE see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | |
Employees | Employees 18,726 | Employees 88,5021% decrease | Employees 34,100 | Employees 1,2338% increase | Employees 94,300 |
Valuation ($) | Valuation ($) 61.7 b | Valuation ($) 27.1 b | Valuation ($) 97.8 b | Valuation ($) N/A | Valuation ($) 2.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥1.9t (FY, 2024) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) $48.2b (FY, 2025) | Revenue (est.) €12.7b (FY, 2023) | Revenue (est.) $58.7b (FY, 2025) |
Cost of goods | Cost of goods ¥415.8b (FY, 2024) | Cost of goods €14b (FY, 2025) | Cost of goods $13.9b (FY, 2025) | Cost of goods €4b (FY, 2023) | Cost of goods $4.9b (FY, 2025) |
Gross profit | Gross profit ¥1.5t (FY, 2024) | Gross profit €32.5b (FY, 2025) | Gross profit $34.3b (FY, 2025) | Gross profit €8.7b (FY, 2023) | Gross profit $54.2b (FY, 2025) |
Net income | Net income ¥295.8b (FY, 2024) | Net income (€3.6b) (FY, 2025) | Net income $7.1b (FY, 2025) | Net income €5.8b (FY, 2023) | Net income $10.2b (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries 83 (FY, 2021) | Countries N/A | Countries N/A | Countries 130 (FY, 2021) |
Manufacturing Facilities | Manufacturing Facilities 13 (Jun, 2022) | Manufacturing Facilities N/A | Manufacturing Facilities 8 (FY, 2021) | Manufacturing Facilities N/A | Manufacturing Facilities N/A |
Trademark Applications | Trademark Applications 46 (Jun, 2022) | Trademark Applications N/A | Trademark Applications N/A | Trademark Applications 1.1 k (Feb, 2024) | Trademark Applications N/A |
Trademarks | Trademarks 112 (Jun, 2022) | Trademarks 1.5 k (FY, 2021) | Trademarks N/A | Trademarks 5.2 k (Feb, 2024) | Trademarks N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 3.5b | Total funding raised $ 15.5m | Total funding raised N/A | Total funding raised $ 1b |

Bayer is a life sciences company specializing in healthcare and nutrition.
View company
Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
View company
Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing.
View company
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company